This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Emboline's UPC security-of-costs ruling in AorticLab case overturned on appeal

( June 20, 2025, 14:36 GMT | Official Statement) -- MLex Summary: Emboline, the claimant in a patent infringement case against AorticLab, has seen Unified Patent Court appeal judges overturn a ruling that required AorticLab to pay 200,000 euros ($230,000) in security for costs. The UPC Court of Appeal ruled that Article 69(4) of the UPC Agreement explicitly allows only defendants — not claimants, like Emboline — to request such security, as the provision aims to shield defendants from financially unstable claimants, not vice versa. The patent at the center of the dispute is Emboline's European Patent 2,129,425, covering a medical technology. See document attached....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Documents

Related Sections